Sign In
Buy NVO
$47.41
-0.0100 (-0.0211%)
At Close: Jun 24, 2026
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
09:00am, Sunday, 17'th Mar 2024
Investors need not be concerned about the FDA's approval delay for Eli Lilly's Alzheimer's drug. Novo Nordisk recently picked up a regulatory win that makes the stock even more attractive.
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
07:00am, Saturday, 16'th Mar 2024
Some health plans and employers are still reluctant to cover Wegovy due to its hefty price tag, which they say could significantly strain their budgets.
7 Mega-Cap Stocks That Can Turn $10,000 Into $1 Million
11:16am, Friday, 15'th Mar 2024
By definition, mega-cap stocks are those which possess a market capitalization above $200 billion. So, investors seeking to turn $10,000 into $1 million through Mega cap companies will be choosing fro
Why Novo Nordisk (NVO) is a Top Momentum Stock for the Long-Term
10:56am, Friday, 15'th Mar 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Novo Nordisk Just Scored a Huge Win. And It's Not Related to Ozempic
10:15am, Friday, 15'th Mar 2024
Novo Nordisk primarily focuses on the diabetes and obesity markets with medications like Ozempic and Wegovy. Wegovy was recently granted an extended indication from the FDA to treat cardiovascular dis
3 Weight-Loss Stocks to Buy as GLP-1 Mania Takes Hold
08:15am, Friday, 15'th Mar 2024
When many investors hear the word mania, they may think of artificial intelligence (AI) stocks or Bitcoin. Both investments have yielded market-beating returns and have room to run higher.
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
05:50am, Friday, 15'th Mar 2024
Pfizer's pipeline already includes two obesity drugs. However, doubts about Pfizer's lead obesity program could make buying Viking a smart move.
Missed Out on Novo Nordisk? This Much Smaller Danish Biotech Could Be the Next Hot Weight-Loss Stock.
05:15am, Thursday, 14'th Mar 2024
Novo Nordisk's $600 billion valuation makes it one of the top healthcare companies in the world. For investors looking for stocks with more upside, upstart Zealand Pharma may fit the bill.
UPS, IBM, NVO: Expect Less Volatility Than Last Year
03:35pm, Wednesday, 13'th Mar 2024
We're bullish on the market this year, notes Andrew Arons. He discusses the long-term market outlook.
America versus Europe: The big-cap stocks face off
08:26am, Wednesday, 13'th Mar 2024
Who is better, the United States of America or the European Union? On the one hand, European citizens are by and large privy to free access to healthcare, though the land of the free is considerably l
Can WeightWatchers Regain Its Mojo after Oprah Steps Down?
07:04am, Wednesday, 13'th Mar 2024
WW International Inc. NASDAQ: WW (WeightWatchers) has had a disastrous 2024, with its shares collapsing 66.7% year-to-date (YTD). The company made a praiseworthy strategic pivot in 2023, acquiring Seq
Why Novo Nordisk Stock Was a Winner Today
08:31pm, Tuesday, 12'th Mar 2024
A research firm added the European pharmaceutical sector star to its focus list. It was among four stocks earning this status.
What Makes Novo Nordisk (NVO) a Strong Momentum Stock: Buy Now?
01:01pm, Tuesday, 12'th Mar 2024
Does Novo Nordisk (NVO) have what it takes to be a top stock pick for momentum investors? Let's find out.
All You Need to Know About Novo Nordisk (NVO) Rating Upgrade to Buy
01:01pm, Tuesday, 12'th Mar 2024
Novo Nordisk (NVO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Novo Nordisk-owner to expand in India this year
11:39am, Tuesday, 12'th Mar 2024
Novo Holdings, the controlling shareholder of Danish obesity drugmaker Novo Nordisk , plans to open an office in India this year to tap innovation and a growing healthcare market, its CEO Kasim Kutay
